82. Optimal Duration of MOUD (Medications for Opioid Use Disorder)

We discuss an article about the benefits of continuing buprenorphine, methadone, and naltrexone long-term. 

 

Hayes CJ, Raciborski RA, Acharya M, Noor NB, Nunes EV, Winhusen TJ. Evaluating the optimal duration of medication treatment for opioid use disorder. Addiction. 2026 Apr;121(4):922-933. doi: 10.1111/add.70211. Epub 2026 Jan 7. PMID: 41501983; PMCID: PMC12980296.  

 

We also discuss increasing reimbursement for smoking cessation counselling, and VA trials of GLP-1s for alcohol use disorder. 

 

StatNews: Quitting smoking is hard. A Medicare change may push doctors to give more help 

Medicare proposed 2027 fee schedule (a little light reading) 

To make public comments on the 2027 fee schedule 

Military Times: VA launches trial to test GLP-1 medication for alcohol use disorder in veterans 

--- 

This podcast offers category 1 and MATE-ACT CME credits through MI CARES and Michigan State University. To get credit for this episode and others, go to this link to make your account, take a brief quiz, and claim your credit. To learn more about opportunities in addiction medicine, visit MI CARES.